Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 3Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 78Cisplatin 66Carboplatin 64Drug Therapy 63Magnetic Resonance Spectroscopy 62Bevacizumab 62Radiotherapy 57Cyclophosphamide 56Gemcitabine 54pembrolizumab 52Capecitabine 50Oxaliplatin 49toripalimab 45Paclitaxel 41tislelizumab 40Standard of Care 39Biopsy 37fludarabine 36Injections 36Fluorouracil 34venetoclax 33Blood Specimen Collection 31Immune Checkpoint Inhibitors 30anlotinib 29Docetaxel 28Surgical Procedures, Operative 27Leucovorin 27Irinotecan 27Dexamethasone 27Nivolumab 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × NPI 2358 × 1 year × Clear all
NCT07361484 2026-01-23

Docetaxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non-Squamous NSCLC After PD-1/PD-L1 Therapy and Platinum Chemotherapy (DUBLIN-4)

BeyondSpring Pharmaceuticals Inc.

Phase 3 Not yet recruiting
442 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡